Aβ amyloid, cognition, and APOE genotype in healthy older adults

Alzheimer's and Dementia

Volumn 9, Issue 5, 2013, Pages 538-545

  Lim, Yen Ying ^a   Ellis, Kathryn A ^a,b   Ames, David ^a,b   Darby, David ^a,c,d   Harrington, Karra ^a   Martins, Ralph N ^e   Masters, Colin L ^a   Rowe, Christopher ^a,f   Savage, Greg ^g   Szoeke, Cassandra ^a,b,h   Villemagne, Victor L ^a,f   Maruff, Paul ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b National Aging Research Institute   (Australia)

^c Scientific Division   (Australia)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^e EDITH COWAN UNIVERSITY   (Australia)

^f AUSTIN HEALTH   (Australia)

^g MACQUARIE UNIVERSITY   (Australia)

^h CSIRO   (Australia)

Author keywords

AIBL; APOE 4; Cerebral A burden; Episodic memory; Healthy older adults

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4;

AGED; ARTICLE; COGNITION; CONTROLLED STUDY; EPISODIC MEMORY; FEMALE; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROPSYCHOLOGY; NORMAL HUMAN; PRIORITY JOURNAL;

AIBL; APOE E4; CEREBRAL AΒ BURDEN; EPISODIC MEMORY; HEALTHY OLDER ADULTS;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; APOLIPOPROTEIN E4; AUSTRALIA; BRAIN; COGNITION; FEMALE; GENOTYPE; HETEROZYGOTE; HUMANS; MALE; MEMORY, EPISODIC; NEUROPSYCHOLOGICAL TESTS;

EID: 84883557408     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2012.07.004     Document Type: Article

References (48)

1. H.J. Aizenstein, R.D. Nebes, J.A. Saxton, J.C. Price, C.A. Mathis, and N.D. Tsopelas Frequent amyloid deposition without significant cognitive impairment among the elderly Arch Neurol 65 2008 1509 1517
2. M. Storandt, M.A. Mintun, D. Head, and J.C. Morris Cognitive decline and brain volume loss as signatures of cerebral amyloid-β peptide deposition identified with Pittsburgh Compound B: Cognitive decline associated with Aβ deposition Arch Neurol 66 2009 1476 1481
3. D.A. Bennett, J.A. Schneider, Z. Arvanitakis, J.F. Kelly, N.T. Aggarwal, and R.C. Shah Neuropathology of older persons without cognitive impairment from two community-based studies Neurology 66 2006 1837 1844 (Pubitemid 44049813)
4. C.C. Rowe, K.A. Ellis, M. Rimajova, P. Bourgeat, K.E. Pike, and G. Jones Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging Neurobiol Aging 31 2010 1275 1283
5. V.L. Villemagne, K.E. Pike, D. Darby, P. Maruff, G. Savage, and S. Ng Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease Neuropsychologia 46 2008 1688 1697
6. C.R. Jack, V.J. Lowe, S.D. Weigand, H.J. Wiste, M.L. Senjem, and D.S. Knopman Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease Brain 132 2009 1355 1365
7. A.J. Furst, G.D. Rabinovici, A.H. Rostomian, T. Steed, A. Alkalay, and C. Racine Cognition, glucose metabolism and amyloid burden in Alzheimer's disease Neurobiol Aging 33 2012 215 225
8. K.E. Pike, G. Savage, V.L. Villemagne, S. Ng, S.A. Moss, and P. Maruff β-amyloid imaging and memory in non-demented individuals: Evidence for preclinical Alzheimer's disease Brain 130 2007 2837 2844 (Pubitemid 350033975)
9. A. Forsberg, O. Almkvist, H. Engler, A. Wall, B. Långström, and A. Nordberg High PIB retention in Alzheimer's disease is an early event with complex relationships with CSF biomarkers and functional parameters Curr Alzheimer Res 7 2010 56 66
10. C.R. Jack, V.J. Lowe, M.L. Senjem, S.D. Weigand, B.J. Kemp, and M.M. Shiung 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment Brain 131 2008 665 680 (Pubitemid 351294719)
11. M.A. Mintun, G.N. LaRossa, Y.I. Sheline, C.S. Dence, S.Y. Lee, and R.H. Mach 11C-PIB in a nondemented population: Potential antecedent marker of Alzheimer disease Neurology 67 2006 446 452 (Pubitemid 44214969)
12. R.A. Sperling, P.S. Aisen, L.A. Beckett, D.A. Bennett, S. Craft, and A.M. Fagan Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup Alzheimer Dementia 7 2011 280 292
13. N. Andreasen, and H. Zetterberg Amyloid-related biomarkers for Alzheimer's disease Curr Med Chem 15 2008 766 771 (Pubitemid 351516792)
14. B. Borroni, E. Premi, M. Di Luca, and M. Padovani Combined biomarkers for early Alzheimer disease diagnosis Curr Med Chem 14 2007 1171 1178 (Pubitemid 46739318)
15. K.E. Pike, K.A. Ellis, V.L. Villemagne, N.M. Good, G. Chetelat, and D. Ames Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study Neuropsychologia 49 2011 2384 2390
16. E.C. Mormino, J.T. Kluth, C.M. Madison, G.D. Rabinovici, S.L. Baker, and B.L. Miller Episodic memory loss is related to hippocampal-mediated B-amyloid deposition in elderly subjects Brain 132 2008 1310 1323
17. K. Kantarci, V. Lowe, S.A. Przybelski, S.D. Weigand, M.L. Senjem, and R.J. Ivnik APOE modifies the association between AB load and cognition in cognitively normal older adults Neurology 78 2012 232 240
18. J.C. Morris, C.M. Roe, C.J. Xiong, A.M. Fagan, A.M. Goate, and D.M. Holtzman APOE predicts AB but not tau Alzheimer's pathology in cognitively normal aging Ann Neurol 67 2010 122 131
19. V.B. Gupta, S.M. Laws, V.L. Villemagne, D. Ames, A.I. Bush, and K.A. Ellis Plasma apolipoprotein E and Alzheimer disease risk: The AIBL study of aging Neurology 76 2011 1091 1098
20. V.L. Villemagne, K.E. Pike, G. Chételat, K.A. Ellis, R.S. Mulligan, and P. Bourgeat Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease Ann Neurol 69 2011 181 192
21. K.A. Ellis, A.I. Bush, D. Darby, D. De Fazio, J. Foster, and P. Hudson The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease Int Psychogeriatr 21 2009 672 687
22. Y.Y. Lim, K.A. Ellis, K. Harrington, D. Ames, R.N. Martins, and C.L. Masters Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarker and Lifestyle (AIBL) study J Clin Exp Neuropsychol 34 2012 345 358
23. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state": A practical method for grading cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
24. J.C. Morris The Clinical Dementia Rating (CDR): Current version and scoring rules Neurology 43 1983 2412 2414
25. D. Wechsler Wechsler Test of Adult Reading: Examiner's manual 2001 The Psychological Corporation San Antonio, TX
26. R.P. Snaith, and A.S. Zigmond The Hospital Anxiety and Depression Scale BMJ 292 1986 344
27. D.C. Delis, J.H. Kramer, E. Kaplan, and B.A. Ober California Verbal Learning Test - second edition (CVLT-II) 2001 The Psychological Corporation San Antonio, TX
28. B.T. Harel, D. Darby, R.H. Pietrzak, K.A. Ellis, P.J. Snyder, and P. Maruff Examining the nature of impairment in visual paired associate learning in amnestic mild cognitive impairment Neuropsychology 25 2011 752 762
29. J. Fredrickson, P. Maruff, M. Woodward, L. Moore, A. Fredrickson, and J. Sach Evaluation of the usability of a brief computerized cognitive screening test in older people for epidemiological studies Neuroepidemiology 34 2010 65 75
30. D. Hammers, E. Spurgeon, K. Ryan, C. Persad, J. Heidebrink, and N. Barbas Reliability of repeated cognitive assessment of dementia using a brief computerized battery Am J Alzheimer Dis Other Dementias 26 2011 326 333
31. P. Maruff, E. Thomas, L. Cysique, B. Brew, A. Collie, and P. Snyder Validity of the CogState brief battery: Relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex Arch Clin Neuropsychol 24 2009 165 178
32. D.N. Lawley A generalization of Fisher's Z test Biometrika 30 1938 180 187
33. J. Cohen Statistical power analysis for the behavioral sciences 2nd ed 1988 Lawrence Erlbaum Mahwah, NJ
34. A. Collie, P. Maruff, R. Shafiq-Antonacci, M. Smith, M. Hallup, and P.R. Schofield Memory decline in healthy older people: Implications for identifying mild cognitive impairment Neurology 56 2001 1533 1538 (Pubitemid 32532266)
35. B.J. Small, A.B. Graves, C.L. McEvoy, F.C. Crawford, M. Mullan, and J.A. Mortimer Is ApoE-ε4 a risk factor for cognitive impairment in normal aging? Neurology 54 2000 2082 2088 (Pubitemid 30397206)
36. M.S. Albert, S.T. DeKosky, D. Dickson, B. Dubois, H.H. Feldman, and N.C. Fox The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging and Alzheimer's Association workgroup Alzheimer Dementia 7 2011 270 279
37. C.R. Jack, D.S. Knopman, W.J. Jagust, L.M. Shaw, P.S. Aisen, and M.W. Weiner Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet Neurol 9 2010 119 128
38. S.B. Sando, S. Melquist, A. Cannon, M.L. Hutton, O. Sletvold, and I. Saltvedt APOE ε4 lowers age at onset and is a high risk factor for Alzheimer's disease: A case control study from central Norway BMC Neurol 8 2008 9
39. M.X. Tang, G. Maestre, W.Y. Tsai, X.H. Liu, L. Feng, and W.Y. Chung Relative risk of Alzheimer disease and age-at-onset distributions based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City Am J Hum Genet 58 1996 574 584 (Pubitemid 26062488)
40. D. Darby, R.H. Pietrzak, J. Fredrickson, M. Woodward, L. Moore, and A. Fredrickson Intra-individual cognitive decline using a brief computerized cognitive screening test Alzheimer Dementia 8 2012 95 104
41. D. Darby, A. Brodtmann, R.H. Pietrzak, J. Fredrickson, M. Woodward, and V. Villemagne Episodic memory decline predicts cortical amyloid status in community-dwelling older adults J Alzheimer Dis 27 2011 627 637
42. S.M. Resnick, J. Sojkova, Y. Zhou, Y. An, W. Ye, and D.P. Holt Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB Neurology 74 2010 807 815
43. C. Proust-Lima, H. Amieva, J.F. Dartigues, and H. Jacqmin-Gadda Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population-based studies Am J Epidemiol 165 2007 344 350 (Pubitemid 46174759)
44. M.C. Greenway, L.H. Lacritz, D. Binegar, M.F. Weiner, A. Lipton, and C.M. Cullum Patterns of verbal memory performance in mild cognitive impairment, Alzheimer's disease and normal aging Cogn Behav Neurol 19 2006 79 84 (Pubitemid 43932795)
45. S. Jungwirth, S. Zehetmayer, P. Bauer, S. Weissgram, K.H. Tragl, and P. Fischer Prediction of Alzheimer dementia with short neuropsychological instruments J Neural Transm 116 2009 1513 1521
46. A. Collie, P. Maruff, D.G. Darby, and M. McStephen The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals J Int Neuropsychol Soc 9 2003 419 428 (Pubitemid 36367331)
47. D. Darby, P. Maruff, A. Collie, and M. McStephen Mild cognitive impairment can be detected by multiple assessments in a single day Neurology 59 2002 1042 1046
48. M.G. Falleti, P. Maruff, A. Collie, and D.G. Darby Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week, and one month test-retest intervals J Clin Exp Neuropsychol 28 2006 1096 1112